Comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118-2125.

ABSTRACT:

SUBMITTER: Knudsen LB 

PROVIDER: S-EPMC3836151 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature